Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia

Hiddo J.L. Heerspink, Austin G. Stack, Robert Terkeltaub, Tom A. Greene, Lesley A. Inker, Magnus Bjursell, Shira Perl, Tord Rikte, Fredrik Erlandsson, Vlado Perkovic

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science